NCT00370825View on ClinicalTrials.gov

Combination Chemotherapy for the Treatment of Indian Kala-Azar

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2006

Conditions
Visceral Leishmaniasis
Interventions
DRUG

Combination therapy with AmBisome and miltefosine

Trial Locations (1)

842001

Kala-azar Medical Research Center, Muzaffarpur

All Listed Sponsors
lead

Banaras Hindu University

OTHER

NCT00370825 - Combination Chemotherapy for the Treatment of Indian Kala-Azar | Biotech Hunter | Biotech Hunter